ورود / عضویت
EN/FA Home About Us Contact Us Media Articles

Comparison of the efficacy of two brands of Triptorelin (Microrelin and Diphereline) in reducing prostate-specific antigen and serum Testosterone in prostate cancer: A double-blinded randomized clinical trial

Background: Gonadotropin-releasing hormone (GnRH) agonists initiate androgen deprivation in treating prostate cancer (PC). Triptorelin is a synthetic GnRH and many of its market brands such as Diphereline have been introduced so far.

Objectives: We compared the efficacy of a sustained-release formulation of Triptorelin (Microrelin), domestically produced in Iran, and compared it with Diphereline in a double-blinded randomized clinical trial.

Patients and Methods: Patients were randomly assigned to Group A (Microrelin S.R. 3.75 mg, Pooyesh Darou, Iran) and Group B (Diphereline S.R. 3.75 mg, IPSEN, France). Each patient received monthly intramuscular injections. Prostate-specific antigen (PSA) and circulatory testosterone were measured at baseline and after one, 3, and 6 months.

Results: Each group contained 40 patients. In Group A, PSA was reduced from 75.78 ± 72.43 ng/mL to 1.93 ± 1.40 ng/mL after 6 months and testosterone was reduced from 3.50 ± 1.12 nmol/L to 0.81 ± 0.05 nmol/L. There was no significant difference between the efficacy of Microrelin and Diphereline. Two patients in the Microrelin Group and one patient in the Diphereline Group failed to reach medical castration (testosterone < 1.7 nmol/L), which illustrates that the power of Microrelin and Dipherelin in initiating medical castration is about 95% and 97.5%, respectively.

Conclusions: Our study showed that Microrelin is as effective as Diphereline in reducing PSA and testosterone and can be recommended to initiate medical castration in patients with PC. Keywords: Prostate Cancer; Prostate-Specific Antigen; Testosterone; Gonadotropin-Releasing Hormone

For more information click here

It is our honor to help patients who are suffering from the disease. We always hope to have a greater share in resolving diseases in the hope of getting rid of any suffering.

Subscribe to Our Newsletter

Subscribe To Newsletter To Stay Up To Date On Our Latest News

Contact Us

Address :No.26 . Nader Alley . Parvin St . West Fatemi St . Tehran . Iran Tel : +982162769000 Fax: +982166908071 Mail: info@homapharmed.com